Agenda
Coming Soon
We have a full agenda for both days, details of both the morning and afternoon sessions can be found below.
Day 1 - Deep Venous Therapies
Time
Events
Speakers
- 0800 - 0855
Registration
- 0855 - 0900
Welcome
Miss Kaji Sritharan, York
Management of Acute DVT
Chairs: Dr Marta Ramirez Ortega & Mr Taha Khan
- 0900 - 0910
Cost effectiveness and QALY - is there sufficient evidence to justify Acute and Chronic DVT Interventions (8+2)
Prof Miltiadis Krokidis, Greece
- 0910 - 0920
Update: EVeR Registry and ongoing DVT Trials (8+2)
Mr Baris Odezemir, Bristol
- 0920 - 0930
Management of Acute DVT – what does best practice look like and how far away are UK units from achieving this? (8+2)
Mr Sandip Nandhra, Newcastle
- 0930 - 0940
PANEL DISCUSSION
Debate
Chairs – Dr Narayanan Thulasidasan & Dr Mert Dumantepe
- 0940 - 1000
DEBATE: All Centres in the UK should offer DVT Interventions
FOR: Prof Dan Carradice, Hull (8+2)
AGAINST: Prof Rob Morgan, London (8+2)
AGAINST: Prof Rob Morgan, London (8+2)
- 1000 - 1020
Coffee Break
- 1205 - 1220
PANEL DISCUSSION
Management of Acute DVT
Chairs: Mr Baris Odezemir & Dr Raj Gali
- 1020 - 1035
Pre-procedure Planning for Acute DVT – My Toolkit and how I Plan for Success (13+2)
Mr Taha Khan, London
- 1035 - 1050
My approach to Stenting in Acute DVT – tips and tricks (13+2)
Dr Marta Ramirez Ortega, Spain
- 1050 - 1105
PANEL DISCUSSION
Mechano-thrombectomy Devices in Acute DVT
Chairs: Dr Olivier Hartung & Dr Andy Wigham
- 1105 - 1205
Which tool for which lesion and why? Case-based Discussion
- Inari ClotTriever
- Aspirex (BD)
- Penumbra
- Angiojet (Boston)
- Inari ClotTriever
- Aspirex (BD)
- Penumbra
- Angiojet (Boston)
Miss Emma Wilton, Oxford (13+2)
Dr Mert Dumantepe, Turkey (13+2)
Dr Narayanan Thulasidasan London (13+2)
Prof Efthymios Avgerinos, Greece (13+2)
- 1205 - 1220
New concepts in the Management of DVT – which anticoagulant / anti-platelet, when and for how long? (13+2)
Dr Karen Breen, London
- 1220 - 1235
AI in Venous Disease – can it revolutionise diagnosis and treatment in deep venous disease? (13+2)
Prof Efthymios Avgerinos, Greece
- 1235 - 1250
PANEL DISCUSSION
- 1250 - 1340
Lunch
Time
Events
Speakers
Management of Chronic DVT
Chairs: Miss Emma Wilton & Prof Efthymios Avgerinos
- 1340 - 1400
Management of Chronic DVT – How to select winners and planning for success (18+2)
Dr Mohammad Barbati, Germany
- 1400 - 1420
Reconstruction of the IVC – tips and tricks (18+2)
Dr Andy Wigham, Oxford
- 1420 - 1435
Surveillance post-stenting, preventing stent occlusion and Management of In-stent Restenosis/Thrombosis - An evidence-based approach (13+2)
Mr Adam Gwozdz, London
- 1435 - 1450
PANEL DISCUSSION
- 1450 - 1510
Coffee
Mixed Cases
Chairs: Dr Mohammad Barbati & Dr Conrad von Stempel
- 1510 - 1525
Stenting in the young female – what is the risk of stent occlusion in subsequent pregnancy (13+2)
Dr Narayanan Thulasidasan, London
- 1525 - 1540
Nutcracker Syndrome – when and how do you treat? (13+2)
Dr Olivier Hartung, France
- 1540 - 1555
Venous TOS – My Practice & Current Evidence (13+2)
Dr Mert Dumantepe, Turkey
- 1555 - 1610
PANEL DISCUSSION
Pulmonary Embolism Thrombectomy
Chairs: Prof Rob Morgan & Prof Miltos Krokidis
- 1610 - 1625
Developing a PE Service – Challenges and Opportunities (13+2)
Dr Conrad von Stempel, London
- 1625 - 1645
My approach to PE Treatment – Options and Strategies (18+2)
Dr Narayan Thulasidasan, London
- 1645 - 1700
PANEL DISCUSSION
- 1700 - 1705
Close of Meeting
Miss Kaji Sritharan, Meeting Director
Day 2 - Peripheral Arterial Therapies
Time
Events
Speakers
- 0800 - 0805
Welcome
Miss Kaji Sritharan, LLES Meeting Director
Breakfast Meeting
Research
Chairs: Mr Andy Thompson & Prof Michael Reijnen
- 0805 - 0820
The SWEDEPAD Trial & Katsanos – where does the truth lie? (12+3)
Prof Athanasios Saratzis, Leicester
- 0820 - 0835
BASIL-2, BASIL-3 and BEST-CLI – an update (12+3)
Mr Matt Popplewell, Birmingham
- 0835 - 0845
BASIL-2, BASIL-3, BEST-CLI & SWEDEPAD – does it change practice (8+2)
Dr Raghuram Lakshminarayan, Hull
- 0845 - 0855
PANEL DISCUSSION
Aorto-Iliac Disease
Chairs: Dr Andy Wigham & Dr Ulrich Beshorner
- 0855 - 0910
CERAB – When I do it, Technical Considerations and Long-term Outcomes (12+3)
Prof Michael Reijnen, Netherlands
- 0910 - 0925
IVL as a primary treatment strategy for aorto-iliac disease – When I do it, Technical Considerations and Outcomes (12+3)
Dr Stefano Fazzini, Italy
- 0925 - 0935
PANEL DISCUSSION
Femoro-popliteal Disease (I)
Chairs: Prof. Martin Andrassy & Dr Rosie Cadwallader
- 0935 - 0950
My algorithm for treating the Common Femoral Artery: plaque morphology and choice of intervention? (12+3)
Dr Ulrich Beshorner, Germany
- 0950 - 1005
Drug-eluting technology – Paclitaxel vs Sirolimus in the SFA - the winners and
losers (12+3)
Prof Sabine Steiner, Germany
- 1005 - 1015
PANEL DISCUSSION
- 1015 - 1035
Coffee
Femoro-popliteal Disease (II)
Chairs: Dr Narayanan Thulasidasan & Prof Sabine Steiner
- 1035 - 1050
Which atherectomy / thrombectomy device – the evidence to support their use (12+3)
Dr Marc Sirvent, Spain
- 1050 - 1105
My approach to Long CTO lesions – my tips for crossing, vessel preparation and stent selection (when needed) (12+3)
Prof Stavros Spiliopoulos, Greece
- 1105 - 1115
Wire Assisted Remote Endarterectomy (WARE) – a hybrid technique for SFA recanalisation (8+2)
Mr Ramasubramanyan Chandrasekar, UK
- 1115 - 1125
IVUS in Popliteal Disease (8+2)
Prof Hany Zayed, London
- 1125 - 1137
Medtronic Sponsored Talk - My Experience using the Hawk Atherectomy Device - making the business case, case selection & how I use it (10+2)
Mr Craig Nesbitt, Newcastle
- 1137 - 1145
PANEL DISCUSSION
Evidence Session (I)
Chairs: Dr Sapna Puppala & Dr Marc Sirvent
- 1150 - 1200
In-stent re-stenosis – what works? (8+2)
Prof. Martin Andrassy, Germany
- 1200 - 1210
Bioresorbable Vascular Scaffolds – where, when and why? (8+2)
Prof Athanasios Diamantopoulos, London
- 1210 - 1220
The Evidence for Sirolimus in PAD (8+2)
Dr Raghuram Lakshminarayan, Hull
- 1220 - 1230
PANEL DISCUSSION
- 1230 - 1315
Lunch
Time
Events
Speakers
Evidence Session (II)
Chairs: Dr Stefano Fazzini & Dr Yann Goeffic
- 1315 - 1330
Robotics in Vascular Surgery – the future is closer than we think (12+3)
Dr Konstantinos Stavroulakkis, Germany
- 1330 - 1340
Diabetic Foot Disease – Recent Advances and Future Direction (8+2)
Professor Dave Russell, Leeds
- 1340 - 1350
To VAC or not to VAC? Results of the SWHSI-2 Trial (8+2)
Professor Dan Carradice, Hull
- 1350 - 1405
Vascular Research: Trials on the Horizon (12+3)
Prof Athanasios Saratzis, Leicester
- 1405 - 1415
PANEL DISCUSSION
Acute Limb Ischaemia
Chair: Prof Stavros Spiliopoulos & Mr Paul Moxey
- 1415 - 1430
The Evidence for Mechanical Thrombectomy vs Lysis vs Surgery for Acute Limb
Ischaemia (12+3)
Prof Yann Gouëffic, France
- 1430 - 1440
Why we need an ALI Trial (8+2)
Mr Sandip Nandhra, Newcastle
- 1440 - 1450
PANEL DISCUSSION
- 1450 - 1510
Coffee
Evidence Session (III)
Chairs: Prof Athanasios Saratzis & Dr Daniel van den Heuvel
- 1510 - 1516
Pedal acceleration time (PAT) is a better indicator of foot perfusion than ankle or toe occlusion pressure indices (4+2)
Mr Steve Wallace, Liverpool
- 1516 - 1522
Managing complex Aortoiliac occlusive disease in the era of Endovascular Surgery (4+2)
Mr Alaa Hassouneh, Chester
- 1522 - 1528
A single-centre retrospective study of the use of Intravascular Lithotripsy (IVL) in CLTI (4+2)
Dr Kamran Hamid, Birmingham
- 1528 - 1543
Variations in amputations in the UK / Europe - Are we getting better at saving legs? (12+2)
Prof. Michael Edmonds, London
- 1543 - 1558
Bridging the gap between primary and secondary care to save legs (12+3)
Prof. Stella Vig, London
- 1558 - 1605
PANEL DISCUSSION
BTK Disease
Chairs: Prof Hany Zayed & Mr Craig Nesbitt
- 1605 - 1620
How the correct imaging below the knee can lead to the best clinical results? (12+3)
Dr Lorenzo Patrone, Italy
- 1620 - 1635
Percutaneous Deep Vein Arterialisation: Off the shelf techniques – how to? And how do they compare to the LimFlow system? (12+3)
Dr Daniel van den Heuvel, Germany
- 1635 - 1650
Tips and tricks to overcome common pitfalls of calcified CLTI – a Case-based Discussion (12+3)
Dr Narayanan Thulasidasan, London
- 1650 - 1705
PANEL DISCUSSION
- 1705 - 1710
Close of Meeting